[S1] Symposium 1 Virology

11:22 〜 11:46

[S1-4] Identification and Characterization of Ensitrelvir as an Oral Antiviral for SARS-CoV-2: Preclinical Efficacy and Broad Anti-Coronavirus Potential

○Michihito Sasaki^1,2, Akihiko Sato^1,2,3, Hirofumi Sawa^1,2, Yasuko Orba^1,2 (1. International Institute for Zoonosis Control, Hokkaido University (Japan), 2. Institute for Vaccine Research and Development, Hokkaido University (Japan), 3. Laboratory for Drug Discovery & Disease Research, Shionogi & Co., Ltd. (Japan))

閲覧にはパスワードが必要です